*Certified third party testing was conducted in 2018 with women aged 21 – 45, over a time frame of two months using our NannoPads and placebo-controlled products. The NannoPad group experienced less pain (at 95% confidence) and fewer days of menstrual pain after using the NannoPad. The result of NannoPad group also shows a significant reduction of painkillers being used for menstrual cramping. For more info regarding to the Nannogenic™ technology, click here for a recent white paper.
Dr. Lisa Benest
MD, Dermatologist certified by American Board of Dermatology
Dr. Sherry Thomas
MD, MPH, FACOG, FPM&RS, Urogynecologist and surgeon